ArticleBMC musculoskeletal disorders2026
Preprocedural superomedial pain localization as a predictor for short-term clinical improvement after cooled radiofrequency ablation in advanced knee osteoarthritis.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCooled radiofrequency ablation (CRFA) has shown clinical benefits in patients with advanced knee osteoarthritis (OA); however, predictors of treatment response remain limited. Preprocedural pain localization may offer a simple and clinically relevant predictor for enhanced patient selection for CRFA. PURPOSE: To evaluate whether preprocedural superomedial pain localization and overall pain site count are associated with clinical outcomes after CRFA in patients with advanced knee OA.
methodsThis prospective cohort study included 47 patients (54 knees) with Kellgren–Lawrence grade 3 or 4 OA who underwent ultrasound-guided genicular nerve block and standardized CRFA. Pain localization was assessed using an 8-zone knee pain map. The primary outcome was the 3-month change in International Knee Documentation Committee (IKDC) score. Secondary outcomes included Lysholm score, visual analog scale (VAS), and Knee Injury and Osteoarthritis Outcome Score (KOOS) domains. Univariate and multivariate regression analyses were performed.
resultsSuperomedial pain, the most common localization (66.7%), was significantly associated with worse baseline IKDC (β = − 8.2, p = 0.02) and KOOS–Pain (β = − 13.9, p = 0.01). However, it was independently associated with greater IKDC improvement after CRFA (β = 9.1, p = 0.02) after adjusting for age, sex, and BMI. Total number of pain sites correlated with worse baseline function but not with treatment response.
conclusionsSuperomedial knee pain was independently associated with superior short-term functional improvement following CRFA. These findings support the utility of pain localization as a prognostic tool for patient selection in advanced knee OA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.